Status:
COMPLETED
Biosensors for Open and Closed-loop Glycemia Control in T1D Patients With Insulin Pump
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In T1D, the destruction of beta-pancreatic cells causes insulin deficiency and requires insulin therapy whose control remains complex: even with recent technologies of continuous measurement and monit...
Detailed Description
Continuous monitoring and linked drug delivery is a novel approach to the treatment of chronic diseases that provides powerful means to improve therapeutic outcomes and quality of patient's life. Type...
Eligibility Criteria
Inclusion
- Patient over 18 years of age
- Patient with type 1 diabetes (T1D)
- Patient being equipped and trained with an external or internan insulin pump linked to a CGM
- Affiliated person or beneficiary of a social security scheme
- Free, informed and written consent
Exclusion
- Patient under 18 years
- Patient not having T2D
- Pregnant or lactating patient
- No consent signed by the patient
Key Trial Info
Start Date :
January 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 27 2024
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04081883
Start Date
January 27 2023
End Date
January 27 2024
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Saint-André
Bordeaux, France, 33000